Tag: NASDAQ:IMMY

Finance

Healthcare Losers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), Evoke Pharma Inc (NASDAQ:EVOK), Cerulean Pharma Inc (NASDAQ:CERU)

On Friday, Inovio Pharmaceuticals Inc (NYSEMKT:INO) announced that its shareholders had approved 1-for-4 reverse stock split of company common stock. Company shares sank more than 5% in morning trading. The company said that the effective date of the reverse stock split would be disclosed at a future date after The company complies with “standard NYSE administrative processes.” The company stock performance was -9.09% in last … Continue reading Healthcare Losers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), Evoke Pharma Inc (NASDAQ:EVOK), Cerulean Pharma Inc (NASDAQ:CERU)

Richard Atkins
Finance

Bearish Stocks At NASDAQ; USA Technologies (NASDAQ:USAT), Metabolix (NASDAQ:MBLX), Amtech Systems, Inc. (NASDAQ:ASYS), Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), CSP Inc. (NASDAQ:CSPI)

Zacks downgraded shares of USA Technologies, Inc. (NASDAQ:USAT) from a hold rating to a sell rating in a research note released on Friday morning. Shares of USA Technologies (NASDAQ:USAT) traded up 1.30% during mid-day trading on Friday, hitting $1.9247. USA Technologies, Inc. (NASDAQ:USAT) stock performance was-5.26% in last session and finished the day at $1.80. Traded volume was 131,000 shares in the last session and … Continue reading Bearish Stocks At NASDAQ; USA Technologies (NASDAQ:USAT), Metabolix (NASDAQ:MBLX), Amtech Systems, Inc. (NASDAQ:ASYS), Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), CSP Inc. (NASDAQ:CSPI)

Jayne Crisman
FB Nasdaq FB Facebook
Finance

Biotech Gainers: Novavax (NASDAQ:NVAX), OXiGENE Inc (NASDAQ:OXGN), Imprimis Pharmaceuticals (NASDAQ:IMMY), Oramed Pharmaceuticals (NASDAQ:ORMP)

Novavax (NASDAQ:NVAX) Director Richard Douglas acquired 50,000 shares of Novavax stock in a transaction that occurred on Tuesday, March 25th. Novavax, Inc. (NASDAQ:NVAX) stock performance was 8.47% in last session and finished the day at $4.48. Traded volume was 7,425,052 million shares in the last session and the average volume of the stock remained 5.05 million shares. The beta of the stock remained 2.15. Novavax, … Continue reading Biotech Gainers: Novavax (NASDAQ:NVAX), OXiGENE Inc (NASDAQ:OXGN), Imprimis Pharmaceuticals (NASDAQ:IMMY), Oramed Pharmaceuticals (NASDAQ:ORMP)

Jason Knox